Flavored Intravenous Ondansetron Administered Orally for the Treatment of Persistent Vomiting

NCT02473887 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroenteritis

Interventions

DRUG: Ondansetron with1:1 ORA - sweet.

Sponsor

Hamad Medical Corporation